Literature DB >> 21331584

Design and efficient production of bovine enterokinase light chain with higher specificity in E. coli.

Haarin Chun1, Keehyoung Joo, Jooyoung Lee, Hang-Cheol Shin.   

Abstract

Enterokinase light chain (EKL) is a serine protease that recognizes Asp-Asp-Asp-Asp-Lys (D(4)K) sequence and cleaves the C-terminal peptide bond of the lysine residue. The utility of EKL as a site-specific cleavage enzyme is hampered by sporadic cleavage at other sites than the canonical D(4)K recognition sequence. In order to produce more site-specific EKL, we have generated several EKL mutants in E. coli with substitutions at Tyr174 and Lys99 using PDI (protein disulfide isomerase) fusion system. Substitution of Tyr174 by basic residues confers higher specificity on EKL. The production of EKL with higher specificity could widen the utility of EKL as a site-specific cleavage enzyme to produce various recombinant proteins with therapeutic or industrial values.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21331584     DOI: 10.1007/s10529-011-0562-3

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  4 in total

1.  Human enteropeptidase light chain: bioengineering of recombinants and kinetic investigations of structure and function.

Authors:  Eliot T Smith; David A Johnson
Journal:  Protein Sci       Date:  2013-03-26       Impact factor: 6.725

2.  Directed evolution for soluble and active periplasmic expression of bovine enterokinase in Escherichia coli.

Authors:  Weiluo Lee; Subhas Pradhan; Cheng Zhang; Niccolo A E Venanzi; Weina Li; Stephen Goldrick; Paul A Dalby
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

Review 3.  An overview of enzymatic reagents for the removal of affinity tags.

Authors:  David S Waugh
Journal:  Protein Expr Purif       Date:  2011-08-19       Impact factor: 1.650

4.  Do-it-yourself histidine-tagged bovine enterokinase: a handy member of the protein engineer's toolbox.

Authors:  Wolfgang Skala; Peter Goettig; Hans Brandstetter
Journal:  J Biotechnol       Date:  2013-10-30       Impact factor: 3.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.